Undefeated Brazilian middleweight prospect Igor Cavalcanti has been hit with a temporary suspension from the Nevada Athletic Commission after testing positive for a banned substance following his high-stakes victory on Dana White’s Contender Series. The positive drug test threatens to derail the momentum of a promising career that recently secured a coveted contract with the Ultimate Fighting Championship.
The Nevada Athletic Commission formally announced the disciplinary action on Tuesday, revealing that Cavalcanti tested positive for 19-norandrosterone in connection with his dominant performance against Oscar Ravello in September. The substance is a notorious and heavily regulated anabolic agent that routinely triggers strict regulatory scrutiny across all major combat sports athletic commissions. A final disciplinary ruling from the commission remains pending, leaving the immediate future of Cavalcanti’s professional fighting career hanging in the balance while regulators review the complete details of the case.
Nevada Temporarily Suspends Igor Cavalcanti After DWCS Win as Manager Cites Prior Nandrolone Treatment
The controversy centers around an impressive milestone in Cavalcanti’s professional journey. During his appearance on Dana White’s Contender Series, the hard-hitting Brazilian delivered a statement performance, earning a first-round stoppage victory over Oscar Ravello. That decisive finish initially appeared to be a life-changing moment, as it immediately secured Cavalcanti a lucrative promotional contract with the Ultimate Fighting Championship, the premier global organization in mixed martial arts.
However, the subsequent adverse analytical finding has cast a shadow over the victory. As regulatory proceedings move forward, the Nevada Athletic Commission has not yet determined whether it will officially overturn the bout’s result to a no-contest or impose additional administrative fines and suspensions. Such decisions typically follow a formal disciplinary hearing where the fighter and their legal or managerial representatives are permitted to present evidence and defend against the allegations.
In response to the developing situation, Cavalcanti’s manager, Lucas Lutkus, came forward to address the positive drug test directly, attributing the presence of the banned substance to legitimate medical treatment administered months prior to the fight for a significant right knee injury. According to Lutkus, the fighter received a course of nandrolone therapy designed to aid his physical recovery following severe structural damage to his knee joint.
"Igor’s previous nandrolone use was part of a medical treatment following a right knee injury involving a medial meniscus tear and cartilage damage," Lutkus said in a detailed statement originally given to MMA Junkie.
Providing a precise timeline to substantiate the medical context of the defense, Lutkus explained that Cavalcanti received three distinct 25-milligram intramuscular injections between February 21 and March 7, 2026. This window of administration occurred well in advance of his September appearance inside the Contender Series apex, which management argues accounts for the lingering metabolites detected in his post-fight drug screening under the stringent anti-doping protocols overseen by athletic regulators.
Furthermore, management emphasized that transparency was maintained with the premier MMA organization prior to the bout stepping inside the cage. Lutkus stated that Cavalcanti disclosed the prior medical treatment to the Ultimate Fighting Championship before his Contender Series appearance, hoping to preempt any administrative misunderstandings regarding his physiological history and therapeutic recovery timeline.
Lutkus also noted that administrative representation shifted during the middle of the year, with All In Sports Management beginning to represent Cavalcanti in June. This transition occurred after the conclusion of the medical treatment in question. Since taking over his management affairs, the agency has worked closely with Cavalcanti’s medical team to gather all necessary clinical documentation, medical records, and expert testimonies required to fully cooperate with the Nevada Athletic Commission’s ongoing disciplinary process.
As the regulatory bodies continue their thorough evaluation of the submitted medical evidence, the combat sports community awaits the final ruling from the Nevada Athletic Commission. The outcome of the upcoming hearing will ultimately determine whether Cavalcanti’s Contender Series victory stands in the history books and how long the newly signed UFC middleweight will be sidelined from active competition as he navigates the early hurdles of his major-league career.
